During the early childhood stage of Duchenne muscular dystrophy (ages 2-5), which finding is commonly observed?

Prepare for the Neuromuscular Interventions Test with flashcards and multiple-choice questions. Each question includes hints and explanations. Get ready to ace your exam!

Multiple Choice

During the early childhood stage of Duchenne muscular dystrophy (ages 2-5), which finding is commonly observed?

Explanation:
The main idea is that Duchenne muscular dystrophy begins with proximal muscle weakness that first disrupts a child’s ability to achieve motor milestones. In the 2–5 year age range, the most common finding is delayed or difficult motor milestones—children may have trouble sitting independently, standing, or walking at the usual ages, and they often require more time or support to develop these skills. This reflects early involvement of hip and thigh muscles and the beginning of progressive weakness. Calf pseudohypertrophy can develop as the disease progresses and fat replaces muscle, so some kids may show calf enlargement, but it’s not as consistently present as milestone delay in this early window. A normal gait would be unlikely given the underlying weakness, and no calf changes would contradict the typical progression of the condition.

The main idea is that Duchenne muscular dystrophy begins with proximal muscle weakness that first disrupts a child’s ability to achieve motor milestones. In the 2–5 year age range, the most common finding is delayed or difficult motor milestones—children may have trouble sitting independently, standing, or walking at the usual ages, and they often require more time or support to develop these skills. This reflects early involvement of hip and thigh muscles and the beginning of progressive weakness. Calf pseudohypertrophy can develop as the disease progresses and fat replaces muscle, so some kids may show calf enlargement, but it’s not as consistently present as milestone delay in this early window. A normal gait would be unlikely given the underlying weakness, and no calf changes would contradict the typical progression of the condition.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy